Tracking problems and possible solutions in the quantitative determination of small molecule drugs and metabolites in biological fluids using liquid chromatography-mass spectrometry (Q36686446)

From Wikidata

Jump to navigation Jump to search

scientific article published on 6 November 2006

Language	Label	Description	Also known as
English	Tracking problems and possible solutions in the quantitative determination of small molecule drugs and metabolites in biological fluids using liquid chromatography-mass spectrometry	scientific article published on 6 November 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

Tracking problems and possible solutions in the quantitative determination of small molecule drugs and metabolites in biological fluids using liquid chromatography-mass spectrometry (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

author name string

Ray Bakhtiar

1

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Tapan K Majumdar

2

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

publication date

6 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Journal of Pharmacological and Toxicological Methods

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

262-278

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

describes a project that uses

liquid chromatography–mass spectrometry

1 reference

based on heuristic

inferred from title

LC/MS/MS analysis of quaternary ammonium drugs and herbicides in whole blood

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Sample to sample carryover: a source of analytical laboratory error and its relevance to integrated clinical chemistry/immunoassay systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

A novel incubation direct injection LC/MS/MS technique for in vitro drug metabolism screening studies involving the CYP 2D6 and the CYP 3A4 isozymes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Poor reproducibility of in-source collisional atmospheric pressure ionization mass spectra of toxicologically relevant drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Validated HPLC/MS/MS assay for CI-1011 in rat plasma and a comparison with an HPLC/UV assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Matrix effects on accurate mass measurements of low-molecular weight compounds using liquid chromatography-electrospray-quadrupole time-of-flight mass spectrometry.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Practical implications of some recent studies in electrospray ionization fundamentals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Stabilizing drug molecules in biological samples

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Simultaneous quantitative analysis of metabolites using ion-pair liquid chromatography-electrospray ionization mass spectrometry.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Evaluation of automated single mass spectrometry to tandem mass spectrometry function switching for comprehensive drug profiling analysis using a quadrupole time-of-flight mass spectrometer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Positive electrospray liquid chromatography/mass spectrometry using high-pH gradients: a way to combine selectivity and sensitivity for a large variety of drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Applications of mass spectrometry in early stages of target based drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Optimizing an ultrafast generic high-performance liquid chromatography/tandem mass spectrometry method for faster discovery pharmacokinetic sample throughput.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

A predictive model for matrix and analyte effects in electrospray ionization of singly-charged ionic analytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Shift in pH of biological fluids during storage and processing: effect on bioanalysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Sensitivity enhancement in liquid chromatography/atmospheric pressure ionization mass spectrometry using derivatization and mobile phase additives

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

The effect of the mobile phase additives on sensitivity in the analysis of peptides and proteins by high-performance liquid chromatography-electrospray mass spectrometry.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Characterization of typical chemical background interferences in atmospheric pressure ionization liquid chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

The use of turbulent flow chromatography and the isocratic focusing effect to achieve on-line cleanup and concentration of neat biological samples for low-level metabolite analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Shortcomings of protein removal prior to high performance liquid chromatographic analysis-A case study using method development for BAY 11-7082.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Quantitative determination of alkylated quaternary amines and their n-hydroxylated metabolites in an enzyme incubation matrix by liquid chromatography electrospray ionization mass spectrometry.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Fast mass spectrometry-based methodologies for pharmaceutical analyses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Sources of artefacts in the electrospray ionization mass spectra of saturated diacylglycerophosphocholines: from condensed phase hydrolysis reactions through to gas phase intercluster reactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Negative ion electrospray high-performance liquid chromatography-mass spectrometry method development for determination of a highly polar phosphonic acid/sulfonic acid compound in plasma. Optimization of ammonium acetate concentration and in-source

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

The need for chromatographic and mass resolution in liquid chromatography/tandem mass spectrometric methods used for quantitation of lactones and corresponding hydroxy acids in biological samples

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

LC-MS Development strategies for quantitative bioanalysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

A strategy for a post-method-validation use of incurred biological samples for establishing the acceptability of a liquid chromatography/tandem mass-spectrometric method for quantitation of drugs in biological samples

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

High performance liquid chromatography mobile phase composition optimization for the quantitative determination of a carboxylic acid compound in human plasma by negative ion electrospray high performance liquid chromatography tandem mass spectrometr

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Effects of mobile-phase additives, solution pH, ionization constant, and analyte concentration on the sensitivities and electrospray ionization mass spectra of nucleoside antiviral agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Quantitative liquid chromatographic-tandem mass spectrometric determination of reserpine in FVB/N mouse plasma using a "chelating" agent (disodium EDTA) for releasing protein-bound analytes during 96-well liquid-liquid extraction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Analysis of androgenic steroid Girard P hydrazones using multistage tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Quantitative analysis of squalamine, a self-ionization-suppressing aminosterol sulfate, in human plasma by LC-MS/MS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS/MS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Liquid chromatography-mass spectrometry/mass spectrometry method development for drug metabolism studies: Examining lipid matrix ionization effects in plasma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Interference of a carbamoyl glucuronide metabolite in quantitative liquid chromatography/tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Noncovalent dimerization of paclitaxel in solution: evidence from electrospray ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Thermally induced N-to-O rearrangement of tert-N-oxides in atmospheric pressure chemical ionization and atmospheric pressure photoionization mass spectrometry: differentiation of N-oxidation from hydroxylation and potential determination of N-oxidat

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

A study of ion suppression effects in electrospray ionization from mobile phase additives and solid-phase extracts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Direct analysis of a polar pharmaceutical compound in plasma using ultra-high flow rate liquid chromatography/mass spectrometry with a mixed-mode column

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Standard line slopes as a measure of a relative matrix effect in quantitative HPLC-MS bioanalysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Comparison of peak shapes obtained with volatile (mass spectrometry-compatible) buffers and conventional buffers in reversed-phase high-performance liquid chromatography of bases on particulate and monolithic columns

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Investigation of matrix effects in bioanalytical high-performance liquid chromatography/tandem mass spectrometric assays: application to drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Adduct formation in quantitative bioanalysis: effect of ionization conditions on paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

High-throughput bioanalysis with simultaneous acquisition of metabolic route data using ultra performance liquid chromatography coupled with time-of-flight mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Mass spectrometry innovations in drug discovery and development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Chemistry for peptide and protein PEGylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Direct sensitive quantitative lC/MS analysis of C-peptide from human urine by two dimensional reverse phase/reverse phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Investigation of EDTA anticoagulant in plasma to improve the throughput of liquid chromatography/tandem mass spectrometric assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Unexpected observation of ion suppression in a liquid chromatography/atmospheric pressure chemical ionization mass spectrometric bioanalytical method

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Effect of high-performance liquid chromatography mobile phase components on sensitivity in negative atmospheric pressure chemical ionization liquid chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Determination of a prostaglandin D2 antagonist and its acyl glucuronide metabolite in human plasma by high performance liquid chromatography with tandem mass spectrometric detection--a lack of MS/MS selectivity between a glucuronide conjugate and a

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Minimization of ion suppression in LC-MS/MS analysis through the application of strong cation exchange solid-phase extraction (SCX-SPE)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Application of co-eluting structural analog internal standards for expanded linear dynamic range in liquid chromatography/electrospray mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Simultaneous quantification of seven active metabolites of roxifiban in human plasma by LC/MS/MS in the presence of an interfering displacer at millimolar concentrations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Ionizable isotopic labeling reagent for relative quantification of amine metabolites by mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Simple means to alleviate sensitivity loss by trifluoroacetic acid (TFA) mobile phases in the hydrophilic interaction chromatography-electrospray tandem mass spectrometric (HILIC-ESI/MS/MS) bioanalysis of basic compounds

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

A critical evaluation of high performance liquid chromatography-electrospray ionisation-mass spectrometry and capillary electrophoresis-electrospray-mass spectrometry for the detection and determination of small molecules of significance in clinical

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Internal standard signal suppression by co-eluting analyte in isotope dilution LC-ESI-MS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Analysis of omeprazole and 5-OH omeprazole in human plasma using hydrophilic interaction chromatography with tandem mass spectrometry (HILIC-MS/MS)--eliminating evaporation and reconstitution steps in 96-well liquid/liquid extraction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Matrix effect in LC-ESI-MS and LC-APCI-MS with off-line and on-line extraction procedures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Monolithic materials: Promises, challenges, achievements

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Synthesis and Evaluation of PEG414, a Novel Formulating Agent that Avoids Analytical Problems Associated with Polydisperse Vehicles such as PEG400

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Fragmentation of N-oxides (deoxygenation) in atmospheric pressure ionization: investigation of the activation process

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Characterization of a technique for rapid pharmacokinetic studies of multiple co-eluting compounds by LC/MS/MS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Effect of signal interference from dosing excipients on pharmacokinetic screening of drug candidates by liquid chromatography/mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Elimination of autosampler carryover in a bioanalytical HPLC-MS/MS method: a case study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

An overview of some recent developments in ionization methods for mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Derivatization for electrospray ionization-mass spectrometry. 4. Alkenes and alkynes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Derivatization for electrospray ionization mass spectrometry. 3. Electrochemically ionizable derivatives

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Column-switching procedures for the fast analysis of drugs in biologic samples

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Derivatization of phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Higher throughput bioanalysis by automation of a protein precipitation assay using a 96-well format with detection by LC-MS/MS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Identification and reduction of ion suppression effects on pharmacokinetic parameters by polyethylene glycol 400

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Determination of chlorpyrifos and its metabolites in rat brain tissue using coupled-column liquid chromatography/electrospray ionization tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

The importance of chromatographic separation in LC/MS/MS quantitation of drugs in biological fluids: detection, characterization, and synthesis of a previously unknown low-level nitrone metabolite of a substance P antagonist

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Favorable effects of weak acids on negative-ion electrospray ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Utility of porous graphitic carbon stationary phase in quantitative liquid chromatography/tandem mass spectrometry bioanalysis: quantitation of diastereomers in plasma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Use of online-dual-column extraction in conjunction with chiral liquid chromatography tandem mass spectrometry for determination of terbutaline enantiomers in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Concerns in the development of an assay for determination of a highly conjugated adsorption-prone compound in human urine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

A 96-well single-pot protein precipitation, liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the determination of muraglitazar, a novel diabetes drug, in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

A study of common discovery dosing formulation components and their potential for causing time-dependent matrix effects in high-performance liquid chromatography tandem mass spectrometry assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Separation of a BMS drug candidate and acyl glucuronide from seven glucuronide positional isomers in rat plasma via high-performance liquid chromatography with tandem mass spectrometric detection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Cone voltage induced in-source dissociation of glucuronides in electrospray and implications in biological analyses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

High-throughput quantification for a drug mixture in rat plasma-a comparison of Ultra Performance liquid chromatography/tandem mass spectrometry with high-performance liquid chromatography/tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

The investigation and the use of high flow column-switching LC/MS/MS as a high-throughput approach for direct plasma sample analysis of single and multiple components in pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

A new approach for evaluating carryover and its influence on quantitation in high-performance liquid chromatography and tandem mass spectrometry assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Protonation in electrospray mass spectrometry: wrong-way-round or right-way-round?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.10.002

7 January 2021

Identifiers

10.1016/J.VASCN.2006.10.002

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36686446&oldid=2152176165"